Inhibition of Arachidonate-Induced Human Platelet Aggregation by a Single Low Oral Dose of Aspirin in Combination with a Thromboxane Synthase Inhibitor

Thromb Haemost 1984; 52(02): 215
DOI: 10.1055/s-0038-1661177

Letter to the Editor

Schattauer GmbH Stuttgart

Chiara Cerletti

Laboratory of Cardiovascular, Clinical Pharmacology, Istituto, di Ricerche Farmacologiche, Mario Negri, Via Eritrea, 62, 20157 Milano, Italy

,

Grazyna Rajtar

Laboratory of Cardiovascular, Clinical Pharmacology, Istituto, di Ricerche Farmacologiche, Mario Negri, Via Eritrea, 62, 20157 Milano, Italy

,

Vittorio Bertelé

Laboratory of Cardiovascular, Clinical Pharmacology, Istituto, di Ricerche Farmacologiche, Mario Negri, Via Eritrea, 62, 20157 Milano, Italy

,

Giovanni de Gaetano

Laboratory of Cardiovascular, Clinical Pharmacology, Istituto, di Ricerche Farmacologiche, Mario Negri, Via Eritrea, 62, 20157 Milano, Italy

References
1 Bertelé V, Cerletti C, Schieppati A, Di Minno G, de Gaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1981; 1: 1057-1058
2 Heptinstall S, Bevan J, Cockbill SR, Hanley SP, Parry MJ. Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thromb Res 1980; 80: 219-230
3 Bertelé V, Falanga A, Tomasiak M, Dejana E, Cerletti C, de Gaetano G. Platelet thromboxane synthetase inhibitors with low doses of aspirin: Possible resolution of the »aspirin dilemma«. Science 1983; 220: 517-519
4 Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69: 1366-1372
5 Editorial. Dazoxiben. Lancet 1983; 1: 627-628
6 Di Minno G, Silver MJ, de Gaetano G. Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol 1979; 43: 637-647
7 Jones EW, Cockbill SR, Cowley AJ, Hanley SP, Heptinstall S. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man. Br J Clin Pharmacol 1983; 15: 39-44